As a result, GLUT1 is rate limiting for glucose import in cancerous tumors, while virtually undetectable in non-tumor and benign tumor tissue (Younes et al., 1995; Cooper et al., 2003; Amann et al., 2009). Here, SLC2A1 is linked to neoplasm.